Neocutis Skin Care
Neocutis developed a technology platform based on an in-depth understanding of scar less wound healing. This platform has multiple applications in wound healing, dermatology and skin care.
Neocutis began with a simple observation: prenatal surgery can be done without scar formation after birth. The “Laboratoire de Médecine Foetale” at the Medical School of the University Hospital of Lausanne has worked extensively with fetal cells since 1995 and resulted in several patent applications. In July 2004, a group of financial investors led by Venture Incubator closed a financial deal. This financing enabled Neocutis to launch its first product in the US market, "Neocutis Bio-restorative Skin Cream"; a cosmeceutical sold only through physicians.
Skin Care Treatments
Neocutis' Bio-restorative Skin Cream with PSP is clinically proven to reduce the appearance of facial wrinkles after only two months of daily usage. It is the first and original skin cream formulated with PSP. PSP is the most complete protein blend of Human Growth Factors and Cytokines and Interleukins that are restorative cells produced by the immune and nervous systems. It also promotes recovery and skin restoration after cosmetic or dermatological procedures such as chemical peels, micro-dermabrasion, laser and/or light treatments, and cosmetic surgery.